2 active not recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 2 |
Follow Kidney Failure: new trials by email Literature Review of Kidney Failure trials Research Report on Kidney Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD Dapagliflozin 10 mg/day (oral), Placebo - Kidney Disease, Chronic, Renal Transplant Failure | Phase 3 | Active not recruiting | University Medical Center Groningen | 1750 | 2022-11-08 | 2026-10-08 |
| DAPAgliflozin for Renal Protection in Heart Transplant Recipients Dapagliflozin 10 mg, Placebo - Heart Transplant Failure, Kidney Failure | Phase 3 | Active not recruiting | Oslo University Hospital | 430 | 2022-06-08 | 2026-07-01 |
Renal Insufficiency (2) · Death (1) · Heart Failure (1) · Renal Insufficiency, Chronic (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Cardiovascular Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Heart Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
dapagliflozin (2)
Oslo University Hospital (1) · University Medical Center Groningen (1)
Netherlands (2) · Australia (1) · Belgium (1) · Germany (1) · Norway (1) · Singapore (1) · Spain (1) · Sweden (1)
Kevin Damman, MD, PhD (1) · Mariusz Szymanski, MD, PhD (1) · Olivier Manintveld, MD, PhD (1) · Oscar Braun, MD, PhD (1) · Ron Gansevoort (1)
PMID 39928546, PMID 37170711, PMID 40840822, PMID 41315742, PMID 41551843, PMID 41667648
2023 (1)